Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

European shares end at near nine-month high on potential easing of virus curbs

11/24/2020 | 12:43pm EST
The German share price index DAX graph at the stock exchange in Frankfurt

(Reuters) - European shares ended higher on Tuesday, as the potential easing of lockdowns in France combined with optimism around the deployment of a coronavirus vaccine as early as the beginning of next year to lift hopes of a swift economic recovery.

The pan-European STOXX 600 index rose 0.8% to its strongest close since late February, supported by strong gains in oil & gas stocks, which were set for their best month on record as crude prices hit their highest levels since late March.

"Oil acts as an economic bellwether and the commodity has been on a tear for the past month, rising by more than 20% in value as markets start to become more optimistic about economic activity amid positive vaccine news," said Russ Mould, investment director at AJ Bell.

The benchmark STOXX 600 has surged 14.5% so far this month and is on track for its highest monthly gain on record.

"Investors are drowning out the noise of potential near-term risk and purely focusing on the vaccine optimism coupled with positive political developments from the U.S." said Craig Erlam, senior market analyst at OANDA.

However, Europe's businesses struggled during the month as fresh lockdown measures forced many firms to temporarily shut shop as a second wave of coronavirus infections swept across the continent.

German shares jumped 1.3%, with exchange operator Deutsche Boerse revealing that the blue-chip index would expand to 40 from the current 30 companies with tougher membership criteria.

Data also showed that Europe's biggest economy grew by a record 8.5% in the third quarter.

France's benchmark CAC 40 rose 1.2% after the country on Monday reported its lowest daily tally of COVID-19 infections since Sept. 28, while investors awaited a speech by President Emmanuel Macron later on Tuesday when he may announce a relaxation of lockdown rules.

Italy's FTSE MIB was the top gainer among European indexes after a report suggested the country would get 16 million shots of the potential COVID-19 vaccine developed by AstraZeneca in the first months of 2021 under a supply deal agreed at a European Union level.

British stocks climbed 1.6% after England said it would introduce a new system allowing the use of testing to shorten quarantine requirements for incoming passengers.

The news lifted travel and leisure stocks, among the worst hit by the pandemic due to restrictions on travel, by 2.7%.

(Reporting by Shriya Ramakrishnan and Shashank Nayar in Bengaluru; Editing by Shounak Dasgupta and Alex Richardson)

By Shriya Ramakrishnan and Shashank Nayar

© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
AJ BELL PLC 0.56% 451.6625 Delayed Quote.3.58%
ASTRAZENECA PLC 0.71% 7647 Delayed Quote.3.66%
CAC 40 0.05% 5616.09 Real-time Quote.1.09%
DEUTSCHE BÖRSE AG 0.11% 133.75 Delayed Quote.-4.09%
LONDON BRENT OIL 0.16% 54.98 Delayed Quote.9.17%
STOXX EUROPE 600 0.11% 408.42 Delayed Quote.2.21%
STOXX ITALY 45 (EUR) -1.06% 101.31 Delayed Quote.0.79%
WTI 0.31% 52.31 Delayed Quote.11.60%
All news about ASTRAZENECA PLC
09:59aIndian companies consider buying vaccines for employees
09:58aASTRAZENECA : WHO hopes poorer nations can access Pfizer vaccine "very soon"
08:34aSouth Africa to get 9 million J&J vaccine shots - ministry
07:21aSinovac says its COVID-19 vaccine more effective with longer dosing interval
06:47aASTRAZENECA : Brazil to begin vaccination campaign on Monday afternoon
06:06aHow Africa Is Leading From Behind in Global Coronavirus Vaccine Race
04:24aDAIICHI SANKYO : Enhertu approved in the US for the treatment of patients with p..
03:42aSouth Africa is promised 9 million J&J vaccine shots - Business Day
03:16aASTRAZENECA : UK says vaccine manufacturing is 'lumpy' but still on course for t..
02:24aASTRAZENECA : Brazil inoculates first citizens against COVID-19; grants 2 vaccin..
More news
Financials (USD)
Sales 2020 26 400 M - -
Net income 2020 2 992 M - -
Net Debt 2020 13 217 M - -
P/E ratio 2020 43,0x
Yield 2020 2,73%
Capitalization 135 B 135 B -
EV / Sales 2020 5,63x
EV / Sales 2021 4,88x
Nbr of Employees 70 600
Free-Float 95,7%
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 25
Average target price 126,21 $
Last Close Price 103,14 $
Spread / Highest target 51,3%
Spread / Average Target 22,4%
Spread / Lowest Target -18,5%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Pam P. Cheng Executive VP-Operations & Information Technology
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON1.86%421 997
ROCHE HOLDING AG2.48%305 385
NOVARTIS AG1.97%218 041
MERCK & CO., INC.1.93%210 954
PFIZER INC.-0.30%203 993